Current literature reports conflicting findings regarding prognostic factors for AITL (4, 21), including age, ECOG performance status, Ann Arbor stage, and laboratory parameters (LDH, CRP, β-MG). The gene discussed is CRP; the disease is angioimmunoblastic T-cell lymphoma.